Concepedia

Delphine Verbeke

DV

Statistics

Publications

6

Citations

371

H-Index

6

Active since

2017

Affiliations

VIB-KU Leuven Center for Cancer Biology(Current)

KU Leuven

Center for Human Genetics

Cancer Research Institute Ghent

VIB-KU Leuven Center for Brain & Disease Research

Delphine Verbeke is an author at VIB-KU Leuven Center for Cancer Biology specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2017–2020

6

Publications

6

Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition

R. Habets, Charles E. de Bock, Lutgarde Serneels et al. · Science Translational Medicine · 2019 · 110 citations · Full text

, , +13

HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development

Charles E. de Bock, Sofie Demeyer, Sandrine Degryse et al. · Cancer Discovery · 2018 · 103 citations · Full text

, , +17

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

Sandrine Degryse, Charles E. de Bock, Sofie Demeyer et al. · Leukemia · 2017 · 88 citations · Full text

, , +15

Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia

Delphine Verbeke, Olga Gielen, Kris Jacobs et al. · HemaSphere · 2019 · 27 citations · Full text

, , +15

The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia

Delphine Verbeke, Sofie Demeyer, Cristina Prieto et al. · Clinical Cancer Research · 2020 · 26 citations · Full text

, , +14

1–5 of 6